Wish you well.
(1) Human organ shortage has lasted over decades and patients are dying while they are on the waiting list worldwide.
The reason for human organ shortage is mainly due to bad preservation methods. New York Huaqi bioengineering developed an organ preservation system that provides organ preservation with no reperfusion injury. The organ preservation system will increase donor organs by reducing discarded organs to help to end up the human organ shortage.
The R&D of New York Huaqi Bioengineering has developed an organ preservation system that prolongs organ preservation time from the current 3-6 hours to 24 hours for hearts, livers, and longs and 96 hours for kidneys.
(2) With experience in the perfusion of organs with oxygen, the R&D has developed an extrapulmonary oxygenation system (EOS). EOS is able to increase arterial oxygen pressure (PaO2) from 40 mmHg up to 90 mmHg in dogs by peritoneal dialysis filled up with nanobubbles containing high pressure of oxygen. The concentration of oxygen nanobubbles is tidily associated with PaO2 and our R&D is working on it for the better. EOS will be a therapy for respiratory system failure. Hypoxemia and hypoxia caused by any reason cannot treat by ventilation would be suitable for EOS therapy. EOS will subvert the medical market.
We are financing at the angel or pre-A series to build up the prototypes of the organ preservation system and EOS.
The following links can tell you more detailed
https://nyhqbio.com
I appreciate any response and any questions from you.
Very respectively,
Lili Xu
Ready to Ask For Funding for your company?
Post a Funding Request